Literature DB >> 17956503

Laboratory diagnosis of pulmonary tuberculosis in TB and HIV endemic settings and the contribution of real time PCR for M. tuberculosis in bronchoalveolar lavage fluid.

Gibson S Kibiki1, Bert Mulder, Andre J A M van der Ven, Noel Sam, Martin J Boeree, Adri van der Zanden, Wil M V Dolmans.   

Abstract

BACKGROUND: Tuberculosis (TB) in Africa is increasing because of the human immunodeficiency virus (HIV) epidemic, and in HIV/AIDS patients it presents atypically. Pulmonary tuberculosis (PTB) in Africa is mainly diagnosed clinically, by chest radiograph or by sputum smear for acid fast bacilli (AFB).
METHODS: We evaluated in 120 HIV-infected patients with chest infection the diagnostic accuracy of AFB smear of sputum and bronchoalveolar lavage (BAL) fluid, sputum Mycobacterium tuberculosis (MTB) culture, real-time PCR and MycoDot serological test, using MTB culture of BAL fluid as gold standard. We correlated PCR cycle threshold values (C(T)) to the culture results. Retrospectively, we evaluated the development of active TB in patients with positive PCR but negative culture.
RESULTS: Culture of BAL fluid identified 28 patients with PTB. Fifty-six patients could not produce adequate sputum. Sputum AFB smear and the serological test had sensitivities of 66.7% and 0%, respectively. PCR with C(T) 40 was positive in 73 patients, 27 of whom were also TB culture positive (96.4% sensitivity and 52.3% specificity of PCR). PCR with C(T) 32 had sensitivity of 85.7% and specificity of 90.9% to diagnose PTB in BAL. No patients with positive PCR but negative culture developed active TB during 18 months follow-up.
CONCLUSION: In these HIV-infected patients, AFB smear and serology had very low sensitivities. PCR of BAL with C(T) value 32 had improved specificity to diagnose active PTB. A prospective follow-up study is warranted in TB/HIV endemic settings, applying real time PCR to both sputum and BAL.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17956503     DOI: 10.1111/j.1365-3156.2007.01907.x

Source DB:  PubMed          Journal:  Trop Med Int Health        ISSN: 1360-2276            Impact factor:   2.622


  14 in total

1.  Be alert to tuberculosis-mediated glomerulonephritis: a retrospective study.

Authors:  L Sun; Q Yuan; J Feng; L Yao; Q Fan; J Ma; L Wang
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-08-07       Impact factor: 3.267

2.  Factors associated with recently transmitted Mycobacterium tuberculosis strain MS0006 in Hinds County, Mississippi.

Authors:  Brian Temple; Awewura Kwara; Imran Sunesara; Leandro Mena; Thomas Dobbs; Harold Henderson; Mike Holcomb; Risa Webb
Journal:  South Med J       Date:  2011-12       Impact factor: 0.954

3.  Tuberculosis of the breast.

Authors:  Salim Baharoon
Journal:  Ann Thorac Med       Date:  2008-07       Impact factor: 2.219

4.  Polymerase chain reaction of secA1 on sputum or oral wash samples for the diagnosis of pulmonary tuberculosis.

Authors:  J Lucian Davis; Laurence Huang; Joseph A Kovacs; Henry Masur; Patrick Murray; Diane V Havlir; William O Worodria; Edwin D Charlebois; Padmini Srikantiah; Adithya Cattamanchi; Charles Huber; Yvonne R Shea; Yuenwah Chow; Steven H Fischer
Journal:  Clin Infect Dis       Date:  2009-03-15       Impact factor: 9.079

5.  Combined real-time PCR and rpoB gene pyrosequencing for rapid identification of Mycobacterium tuberculosis and determination of rifampin resistance directly in clinical specimens.

Authors:  Tanya A Halse; Justine Edwards; Phyllis L Cunningham; William J Wolfgang; Nellie B Dumas; Vincent E Escuyer; Kimberlee A Musser
Journal:  J Clin Microbiol       Date:  2010-01-27       Impact factor: 5.948

6.  Antiretroviral treatment-associated tuberculosis in a prospective cohort of HIV-infected patients starting ART.

Authors:  William Worodria; Marguerite Massinga-Loembe; Harriet Mayanja-Kizza; Jane Namaganda; Andrew Kambugu; Yukari C Manabe; Luc Kestens; Robert Colebunders
Journal:  Clin Dev Immunol       Date:  2010-12-08

7.  What are the factors affecting the recovery rate of bronchoalveolar lavage fluid?

Authors:  Kohei Shikano; Mitsuhiro Abe; Yuki Shiko; Kenji Tsushima; Keiichiro Yoshioka; Tsukasa Ishiwata; Takeshi Kawasaki; Jun Ikari; Jiro Terada; Yohei Kawasaki; Koichiro Tatsumi
Journal:  Clin Respir J       Date:  2021-12-06       Impact factor: 1.761

8.  Comparison of overnight pooled and standard sputum collection method for patients with suspected pulmonary tuberculosis in northern Tanzania.

Authors:  Stellah G Mpagama; Charles Mtabho; Solomon Mwaigwisya; Liberate J Mleoh; I Marion Sumari-de Boer; Scott K Heysell; Eric R Houpt; Gibson S Kibiki
Journal:  Tuberc Res Treat       Date:  2012-01-19

9.  Quantitative real-time PCR (q-PCR) for sputum smear diagnosis of pulmonary tuberculosis among people with HIV/AIDS.

Authors:  Yvana Maria Maia de Albuquerque; Ana Luiza Magalhães de Andrade Lima; Ana Kelly Lins; Marcelo Magalhães; Vera Magalhães
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2014 Mar-Apr       Impact factor: 1.846

10.  Cost-effectiveness of point-of-care digital chest-x-ray in HIV patients with pulmonary mycobacterial infections in Nigeria.

Authors:  Gambo Aliyu; Samer S El-Kamary; Alash'le Abimiku; Laura Hungerford; Joshua Obasanya; William Blattner
Journal:  BMC Infect Dis       Date:  2014-12-13       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.